Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons..
We conducted a retrospective study of 17 transplant recipients with carbapenem-resistant Klebsiella pneumoniae bacteremia, and described epidemiology, clinical characteristics and strain genotypes. Eighty-eight percent (15/17) of patients were liver or intestinal transplant recipients. Outcomes were death due to septic shock (18%), cure (24%) and persistent (>7 days) or recurrent bacteremia (29% each). Thirty- and 90-day mortality was 18% and 47%, respectively. Patients who were cured received at least one active antimicrobial agent and underwent source control interventions. Forty-one percent (7/17) of patients had intra-abdominal infections; all except one developed persistent/recurrent bacteremia despite drainage. Two patients tolerated persistent bacteremia for >300 days. All patients except one were infected with sequence type 258 (ST258), K. pneumoniae carbapenemase (KPC)-2-producing strains harboring a mutant ompK35 porin gene; the exception was infected with an ST37, KPC-3-producing strain. Seventy-one percent (12/17) of patients were infected with ST258 ompK36 mutant strains. In two patients, persistent bacteremia was caused by two strains with different ompK36 genotypes. Three ompK36 mutations were associated with significantly higher carbapenem minimum inhibitory concentrations than wild-type ompK36. Pulse-field gel electrophoresis identified a single ST258 lineage; serial strains from individual patients were indistinguishable. In conclusion, KPC-K. pneumoniae bacteremia exhibited highly diverse clinical courses following transplantation, and was caused by clonal ST258 strains with different ompK36 genotypes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 13(2013), 10 vom: 05. Okt., Seite 2619-33 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Clancy, C J [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 27.05.2014 Date Revised 24.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ajt.12424 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM230643817 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM230643817 | ||
| 003 | DE-627 | ||
| 005 | 20231224084909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ajt.12424 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0768.xml |
| 035 | |a (DE-627)NLM230643817 | ||
| 035 | |a (NLM)24011185 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Clancy, C J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.05.2014 | ||
| 500 | |a Date Revised 24.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons. | ||
| 520 | |a We conducted a retrospective study of 17 transplant recipients with carbapenem-resistant Klebsiella pneumoniae bacteremia, and described epidemiology, clinical characteristics and strain genotypes. Eighty-eight percent (15/17) of patients were liver or intestinal transplant recipients. Outcomes were death due to septic shock (18%), cure (24%) and persistent (>7 days) or recurrent bacteremia (29% each). Thirty- and 90-day mortality was 18% and 47%, respectively. Patients who were cured received at least one active antimicrobial agent and underwent source control interventions. Forty-one percent (7/17) of patients had intra-abdominal infections; all except one developed persistent/recurrent bacteremia despite drainage. Two patients tolerated persistent bacteremia for >300 days. All patients except one were infected with sequence type 258 (ST258), K. pneumoniae carbapenemase (KPC)-2-producing strains harboring a mutant ompK35 porin gene; the exception was infected with an ST37, KPC-3-producing strain. Seventy-one percent (12/17) of patients were infected with ST258 ompK36 mutant strains. In two patients, persistent bacteremia was caused by two strains with different ompK36 genotypes. Three ompK36 mutations were associated with significantly higher carbapenem minimum inhibitory concentrations than wild-type ompK36. Pulse-field gel electrophoresis identified a single ST258 lineage; serial strains from individual patients were indistinguishable. In conclusion, KPC-K. pneumoniae bacteremia exhibited highly diverse clinical courses following transplantation, and was caused by clonal ST258 strains with different ompK36 genotypes | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Bacteremia | |
| 650 | 4 | |a Klebsiella pneumoniae | |
| 650 | 4 | |a Klebsiella pneumoniae carbapenemase | |
| 650 | 4 | |a ST258 | |
| 650 | 4 | |a transplantation | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Carbapenems |2 NLM | |
| 650 | 7 | |a DNA, Bacterial |2 NLM | |
| 700 | 1 | |a Chen, L |e verfasserin |4 aut | |
| 700 | 1 | |a Shields, R K |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, S |e verfasserin |4 aut | |
| 700 | 1 | |a Chavda, K D |e verfasserin |4 aut | |
| 700 | 1 | |a Hao, B |e verfasserin |4 aut | |
| 700 | 1 | |a Hong, J H |e verfasserin |4 aut | |
| 700 | 1 | |a Doi, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Kwak, E J |e verfasserin |4 aut | |
| 700 | 1 | |a Silveira, F P |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel-Massih, R |e verfasserin |4 aut | |
| 700 | 1 | |a Bogdanovich, T |e verfasserin |4 aut | |
| 700 | 1 | |a Humar, A |e verfasserin |4 aut | |
| 700 | 1 | |a Perlin, D S |e verfasserin |4 aut | |
| 700 | 1 | |a Kreiswirth, B N |e verfasserin |4 aut | |
| 700 | 1 | |a Hong Nguyen, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 13(2013), 10 vom: 05. Okt., Seite 2619-33 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2013 |g number:10 |g day:05 |g month:10 |g pages:2619-33 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ajt.12424 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2013 |e 10 |b 05 |c 10 |h 2619-33 | ||